BioMS Medical reports results of exploratory phase II trial of dirucotide in relapsing remitting multiple... ( Toronto Stock Exchange Symbol: MS ...)

BioMS Medical reports results of exploratory phase II trial of dirucotide in relapsing remitting multiple sclerosis

Date:1/30/2009

Toronto Stock Exchange Symbol: MS

EDMONTON, Jan. 30 /PRNewswire-FirstCall/ - BioMS Medical Corp. (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced results from MINDSET-01, an exploratory phase II clinical trial evaluating dirucotide in patients with relapsing-remitting MS. The lead clinical development program for dirucotide is for secondary progressive MS where it is being evaluated in two ongoing phase III trials in the United States, Canada and Europe, with results from the Canadian and European MAESTRO-01 trial expected in the second half of 2009.

The results of the MINDSET-01 study showed that dirucotide did not meet its primary endpoint, annualized relapse rate or associated secondary MRI endpoints. Dirucotide did meet certain secondary endpoints related to the progression of the disease, including mean change from baseline in the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) score. The EDSS is a method of quantifying disability in MS, while the MSFC evaluates additional functional parameters. Measuring changes in EDSS and MSFC are primary and secondary outcomes in the ongoing phase III secondary progressive MS trials.

The data also showed that dirucotide was generally well tolerated. The most common side effects reported were redness and burning sensation at the injection site. No patients withdrew due to adverse events.

BioMS and its partner Eli Lilly & Company (Lilly) will continue to analyze the results of this exploratory phase II trial. Under the terms of the licensing agreement with Lilly, no milestone payment was associated with this trial.

"We are encouraged that dirucotide has demonstrated an effect on certain clinical measures of disease progression, this time in the earlier form of the disease," said Kevin Giese, President and CEO of BioMS Medical. "Dirucotide was developed as a potential treatment f
'/>"/>

SOURCE BioMS Medical Corp.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5
Related biology technology :

1. BioMS Medical recognized at Scrip Awards 2008
2. BioMS Medical Announces Third Quarter 2008 Results
3. BioMS Medical to present at Rodman and Renshaw Annual Healthcare Conference
4. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
5. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
6. BioMS Medical announces receipt of milestone payment from Eli Lilly and Company
7. BioMS Medical to present at Sachs Associates Biotech in Europe Forum
8. BioMS Medical to present at UBS Global Life Sciences Conference
9. BioMS Medicals lead drug, dirucotide (MBP8298) for the treatment of multiple sclerosis, receives fast track designation from FDA
10. BioMS Medical announces its intention to renew a normal course issuer bid
11. BioMS Medical announces positive interim analysis on phase III trial of dirucotide (MBP8298) for multiple sclerosis

Post Your Comments:

(Date:5/18/2012)... -- Sequenom, Inc. (NASDAQ: SQNM ), a ... announced that a new publication from the large Women ... for Molecular Medicine,s (Sequenom CMM) MaterniT21 PLUS ... peer-reviewed journal, Prenatal Diagnosis . Along with this ... week ended May 12, 2012, Sequenom CMM has processed ...

(Date:5/17/2012)... 16, 2012 In an effort to voice concern ... (PIDD), the Immune Deficiency Foundation (IDF) offered oral testimony ... Administration (FDA) public hearing on draft guidance of biosimilars ... therapies from the biosimilars pathways in order to protect ... PIDD occurs in people born with an immune system ...

(Date:5/16/2012)... able to reach for and sip from a drink on ... years by using her thoughts to direct a robotic ... Institutes of Health, is evaluating the safety and feasibility of ... This is a type of brain-computer interface (BCI) intended to ... , A report published today in Nature describes ...

(Date:5/16/2012)... May 16, 2012 Reportlinker.com ... report is available in its catalogue: ... http://www.reportlinker.com/p090668/Global-Biotechnology-Instrumentation-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_ ... markets for Biotechnology Instrumentation in US$ ... DNA Synthesizers, Protein/Peptide Synthesizers, DNA Sequencers, ...

[0] Study In Prenatal Diagnosis Finds Sequenom CMM's MaterniT21™ PLUS Lab-developed Test Accurately Detects Fetal Trisomies In Pregnant Women Carrying Twins Or Triplets [0] Immune Deficiency Foundation Urges FDA To Exempt Immunoglobulin From Biosimilars Pathway [0] Paralyzed individuals use thought-controlled robotic arm to reach and grasp [0] Global Biotechnology Instrumentation Industry

... CHAPEL HILL, N.C., June 18 To thrive ... need to,understand that a winning sales performance doesn,t ... their sales forces, then,measure the forces, field-performance to ... research study reveals that best-in-class,companies allow their sales ...

... Inc. (OTC Bulletin Board: SYVC), a specialty,pharmaceutical company, ... LLC (Kirk) during the past year has added ... clients that includes Target,Walgreens, Family Dollar, HEB and ... are all over-the-counter (OTC) private label or "store,brand" ...

... CHESHIRE, Conn., June 18 Alexion,Pharmaceuticals, Inc. (Nasdaq: ... Officer of Alexion Pharmaceuticals, will present at the,Jefferies & ... at 4:15,p.m., ET on Wednesday, June 25, 2008., ... available live. You can,access the webcast at: http://www.alexionpharm.com ...

Other Biology Technology:Increasing Sales Productivity Through Superior Sales Force Performance Management 2 Synovics Pharmaceuticals Announces Continued Growth of Customer Relationships 2 Synovics Pharmaceuticals Announces Continued Growth of Customer Relationships 3 Synovics Pharmaceuticals Announces Continued Growth of Customer Relationships 4 Synovics Pharmaceuticals Announces Continued Growth of Customer Relationships 5

Increasing Sales Productivity Through Superior Sales Force Performance Management Synovics Pharmaceuticals Announces Continued Growth of Customer Relationships Alexion to Present at the Jefferies & Co. 2nd Annual Healthcare Conference

(Date:5/21/2012)... Purdue University are working with the U.S. Army ... Center to create a new type of "bioactive" coating ... caused by head trauma from bomb blasts. , "Stents ... the site of an aneurism to help heal the ... Allain, an associate professor of nuclear engineering. "Aneurisms are ...

(Date:5/21/2012)... mercury in plants and animals, a new study by ... Aquarium has compared levels of the chemical in captive ... animals were fed a controlled diet, while the wild ... of the toxic metal., The study found lower levels ... wild dolphins tested off the Atlantic and Gulf coasts ...

(Date:5/21/2012)... a combination of cues in their hunting sequence - capture, ... catch and consume and which ones they are better off ... first listen to their prey, then they assess its size, ... Page and her team from the Smithsonian Tropical Research Institute ... - The Science of Nature . , To survive, predators ...

Breaking Biology News(10 mins):Purdue professor to speak before Congress about nanotechnology in brain treatment research 2 Purdue professor to speak before Congress about nanotechnology in brain treatment research 3 Mercury in dolphins: Study compares toxin levels in captive and wild sea mammals 2 Mercury in dolphins: Study compares toxin levels in captive and wild sea mammals 3 What sounds good doesn't always taste good 2 Henry Ford physicist awarded for cancer radiation therapy research 76678 1 Henry Ford physicist awarded for cancer radiation therapy research 76678 2 Study identifies flaws in Medicare prescription drug program 76676 1 Study identifies flaws in Medicare prescription drug program 76676 2 American Chemical Society co hosts Science and Society discussion on food safety on Nov 1 76674 1 American Chemical Society co hosts Science and Society discussion on food safety on Nov 1 76674 2

[0] Purdue professor to speak before Congress about nanotechnology in brain treatment research [0] Mercury in dolphins: Study compares toxin levels in captive and wild sea mammals [0] What sounds good doesn't always taste good

... A study of populations of tiny water fleas is ... predictions about the ecological consequences of environmental change. , The ... Nature . The water flea, called Daphnia, plays a key ... Roger Nisbet, an ecologist based at the University of California, ...

... 30, 2008) The world,s rarest big cat is alive ... according to researchers from the Wildlife Conservation Society (WCS) who ... last week., The capture was made in Primorsky Krai along ... and the Russian Academy of Sciences Institute of Biology and ...

... in developing a water treatment system for industrial oil ... other commercially available tertiary treatments, leaving water so clean ... without endangering flora or fauna. , Wastewater from ships, ... with toxic compounds. Stringent EU regulations apply to its ...

Other Biology News:Studies of small water fleas help ecologists understand population dynamics 2 World's rarest big cat gets a check-up 2 World's rarest big cat gets a check-up 3 Cleaning heavily polluted water at a fraction of the cost 2 Cleaning heavily polluted water at a fraction of the cost 3

Studies of small water fleas help ecologists understand population dynamics World's rarest big cat gets a check-up Cleaning heavily polluted water at a fraction of the cost

adult...

Porcine Serum Available Anticoagulants: N-02: Citrate N-04: Heparin (Na) N-06: K2EDTA N-08: Potassium Oxalate N-10: EDTA (Na) N-03: Alsevers N-05: ACD N-07: CPD N-09: K3EDTA N-11...

... Guinea Pig serum is collected from fasted Guinea ... Citrate N-04: Heparin (Na) ... N-10: EDTA (Na) N-03: ... CPD N-09: K3EDTA N-11: ...

EPH electrode, anode, 1. Category: Electrophoresis Systems & Standards & Reagents, IEF & SDS-PAGE & 2-D Electrophoresis, Multiphor II Kits & Components and Accessories....

Biology Products:

Porcine Serum from Irvine Scientific Porcine Serum from Innovative Research Guinea Pig Serum from Innovative Research EPH electrode, anode from GE Healthcare, formerly Amersham Biosciences

BioMS Medical reports results of exploratory phase II trial of dirucotide in relapsing remitting multiple...( Toronto Stock Exchange Symbol: MS ...)